66 results
8-K
EX-10.1
LXRX
Lexicon Pharmaceuticals Inc
11 Mar 24
Lexicon Pharmaceuticals Reports Fourth Quarter 2023
7:26am
upon written advice of its counsel, a conflict of interest exists between such person and the indemnifying party with respect to such claims (in which
8-K
EX-1.1
LXRX
Lexicon Pharmaceuticals Inc
2 Jun 23
Lexicon Announces Pricing of $125 Million Public Offering and Concurrent Private Placement
4:31pm
counsel if (i) the use of counsel chosen by the indemnifying party to represent the indemnified party would present such counsel with a conflict … of interest, (ii) the actual or potential defendants in, or targets of, any such action include both the indemnified party and the indemnifying party
8-K
EX-1.1
LXRX
Lexicon Pharmaceuticals Inc
29 Jul 22
Lexicon Announces Proposed Public Offering of Common Stock
5:18pm
to represent the indemnified party would present such counsel with a conflict of interest, (ii) the actual or potential defendants in, or targets of, any
8-K
EX-10.2
xvddnb9kfdaynmd
11 Dec 20
Lexicon Announces Offering of Common Stock
5:28pm
424B2
5qes20pzrt knut
24 Nov 14
Prospectus for primary offering
12:00am
8-K
EX-99.4
dc3xt974er c5gs
20 Nov 14
Lexicon Announces Proposed Common Stock Offering
12:00am